Apressin

Country of origin: Russia
Pharm-Group: Peripheral vasodilators

Manufacturers: ICN October (Russia)
International name: Hydralazine
Dosage forms: film-coated tablets 10 mg, film-coated tablets 25 mg
Composition: Active substance - Hydralazine.
Indications for use: Arterial hypertension, hypertensive crisis, congestive heart failure with high afterload, eclampsia.
Contraindications: Hypersensitivity, severe arterial atherosclerosis, systemic lupus erythematosus, peripheral neuropathies.
Side effects: Headache, dizziness, fever, hypotension, tachycardia, cardialgia, angina pectoris, hot flashes, sweating, lacrimation, nausea, vomiting, lupus-like syndrome.
Interaction: No information.
Overdose: No information.
Special instructions: Prescribe with caution for coronary insufficiency. It forms colored complexes with iron, and therefore contact of the moistened preparation or its solutions with iron objects should be avoided.
Literature: Encyclopedia of Medicines 2003.